Canada Pension Plan Investment Board’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Buy
+9,200
New +$255K ﹤0.01% 1544
2023
Q1
Sell
-1,399
Closed -$54.7K 1072
2022
Q4
$54.7K Sell
1,399
-2,100
-60% -$94.1K ﹤0.01% 1069
2022
Q3
$167K Sell
3,499
-1,800
-34% -$103K ﹤0.01% 1048
2022
Q2
$205K Buy
5,299
+3,800
+254% +$151K ﹤0.01% 1077
2022
Q1
$86K Buy
+1,499
New +$98.3K ﹤0.01% 1192

Other funds holding BEAM

Canada Pension Plan Investment Board's BEAM Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 9,200 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #1544 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in BEAM as recently as Q4 2022.

Canada Pension Plan Investment Board first reported a position in BEAM in Q1 2022 and has held it in 5 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Canada Pension Plan Investment Board held 9,200 shares of Beam Therapeutics worth $219K as of Q1 2026.
  • Beam Therapeutics was a new Canada Pension Plan Investment Board position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1544 holding.
  • Canada Pension Plan Investment Board first reported a position in Beam Therapeutics in Q1 2022 and has held it in 5 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.